BACKGROUND: We used self-administered vaginal swabs to assess the incidence and clearance of carcinogenic human papillomavirus (HPV) infections in rural Rakai, Uganda. METHODS: Women provided self-administered vaginal swab at annual home-based visits. Type-specific carcinogenic HPV incidence and clearance and risk factors were assessed. RESULTS: Carcinogenic HPV incidence was 17.3 per 100 person-years among HIV-positive women compared with 7.0 per 100 person-years among HIV-negative women (P < 0.001). HPV-51 had the highest incidence followed by HPV-16 (1.8 per 100 and 1.5 per 100 person-years, respectively). In multivariate model, HIV-positive women were twice as likely to have incident infection compared with HIV-negative women. Younger women were at higher risk for incident infection, as were women with higher lifetime and recent sexual partners, and high perception of AIDS. Married women were less likely to have incident infection. Approximately half of all carcinogenic HPV infections cleared over the study follow-up of 3 years. HPV-31, HPV-35, and HPV-16 had the lowest clearance (16.7%, 27.9%, and 38.3%, respectively). In multivariate model, HIV-positive, women over 30 years with higher HPV viral, burden and more lifetime sex partners were less likely to clear infections. CONCLUSIONS: Self-collected vaginal swabs provide accurate HPV exposure assessment for studying HPV exposure and epidemiology and can be an important tool for research in populations unwilling to undergo pelvic exam.
BACKGROUND: We used self-administered vaginal swabs to assess the incidence and clearance of carcinogenic human papillomavirus (HPV) infections in rural Rakai, Uganda. METHODS:Women provided self-administered vaginal swab at annual home-based visits. Type-specific carcinogenic HPV incidence and clearance and risk factors were assessed. RESULTS:Carcinogenic HPV incidence was 17.3 per 100 person-years among HIV-positive women compared with 7.0 per 100 person-years among HIV-negative women (P < 0.001). HPV-51 had the highest incidence followed by HPV-16 (1.8 per 100 and 1.5 per 100 person-years, respectively). In multivariate model, HIV-positive women were twice as likely to have incident infection compared with HIV-negative women. Younger women were at higher risk for incident infection, as were women with higher lifetime and recent sexual partners, and high perception of AIDS. Married women were less likely to have incident infection. Approximately half of all carcinogenic HPV infections cleared over the study follow-up of 3 years. HPV-31, HPV-35, and HPV-16 had the lowest clearance (16.7%, 27.9%, and 38.3%, respectively). In multivariate model, HIV-positive, women over 30 years with higher HPV viral, burden and more lifetime sex partners were less likely to clear infections. CONCLUSIONS: Self-collected vaginal swabs provide accurate HPV exposure assessment for studying HPV exposure and epidemiology and can be an important tool for research in populations unwilling to undergo pelvic exam.
Authors: P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple Journal: J Clin Microbiol Date: 2000-01 Impact factor: 5.948
Authors: Susie Baldwin; Carlos Santos; Elena Mendez Brown; Thomas Nuño; Anna Giuliano; John Davis; Francisco Garcia Journal: Gynecol Oncol Date: 2005-05 Impact factor: 5.482
Authors: Harriet Richardson; Gail Kelsall; Pierre Tellier; Hélène Voyer; Michal Abrahamowicz; Alex Ferenczy; François Coutlée; Eduardo L Franco Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-06 Impact factor: 4.254
Authors: Jessica A Kahn; Gail B Slap; Bin Huang; Susan L Rosenthal; Abbigail M Wanchick; Linda M Kollar; Paula A Hillard; David Witte; Pam Groen; David I Bernstein Journal: Obstet Gynecol Date: 2004-05 Impact factor: 7.661
Authors: Ronald H Gray; David Serwadda; Xiangrong Kong; Frederick Makumbi; Godfrey Kigozi; Patti E Gravitt; Stephen Watya; Fred Nalugoda; Victor Ssempijja; Aaron A R Tobian; Noah Kiwanuka; Lawrence H Moulton; Nelson K Sewankambo; Steven J Reynolds; Thomas C Quinn; Boaz Iga; Oliver Laeyendecker; Amy E Oliver; Maria J Wawer Journal: J Infect Dis Date: 2010-05-15 Impact factor: 5.226
Authors: David Serwadda; Maria J Wawer; Frederick Makumbi; Xiangrong Kong; Godfrey Kigozi; Patti Gravitt; Stephen Watya; Fred Nalugoda; Victor Ssempijja; Aaron A R Tobian; Noah Kiwanuka; Lawrence H Moulton; Nelson K Sewankambo; Steven J Reynolds; Thomas C Quinn; Amy E Oliver; Boaz Iga; Oliver Laeyendecker; Ronald H Gray Journal: J Infect Dis Date: 2010-05-15 Impact factor: 5.226
Authors: Giulia Calenda; Guillermo Villegas; Patrick Barnable; Claudia Litterst; Keith Levendosky; Agegnehu Gettie; Michael L Cooney; James Blanchard; José A Fernández-Romero; Thomas M Zydowsky; Natalia Teleshova Journal: J Acquir Immune Defic Syndr Date: 2017-03-01 Impact factor: 3.731
Authors: Karolina Louvanto; Kari J Syrjänen; Marjut A M Rintala; Seija E Grénman; Stina M Syrjänen Journal: J Clin Microbiol Date: 2010-06-16 Impact factor: 5.948
Authors: Cecily Banura; Sven Sandin; Leen-Jan van Doorn; Wim Quint; Bernhard Kleter; Fred Wabwire-Mangen; Edward K Mbidde; Elisabete Weiderpass Journal: Infect Agent Cancer Date: 2010-04-09 Impact factor: 2.965
Authors: Danielle M Backes; Peter J F Snijders; Michael G Hudgens; Robert C Bailey; Martijn Bogaarts; Kawango Agot; Walter Agingu; Stephen Moses; Chris J L M Meijer; Jennifer S Smith Journal: Sex Transm Infect Date: 2012-09-01 Impact factor: 3.519